January 25, 2018 / 12:20 PM / 9 months ago

BRIEF-Anhui Anke Biotechnology Group to acquire approval for clinical trial and technique of monoclonal antibody injection

Jan 25(Reuters) - Anhui Anke Biotechnology Group Co Ltd

* Says co plans to acquire approval for clinical trial and technique of a kind of monoclonal antibody injection from Jiangsu Aosaikang Pharmaceutical Co Ltd (seller), at the price of 50 million yuan

* Say co also needs to pay sales commissions to seller

Source text in Chinese: goo.gl/m4pD9h

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below